Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07586969Completed
Randomised, open-label trial in polycystic ovary syndrome (PCOS) (3 arms), sponsored by The University of Lahore. Primary endpoint: Follicle-Stimulating Hormone and Luteinizing Hormone at 2 months. Started Sep 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07586969.